Stay updated on Omalizumab in Multi-Allergen OIT Clinical Trial

Sign up to get notified when there's something new on the Omalizumab in Multi-Allergen OIT Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Omalizumab in Multi-Allergen OIT Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the prior study content with a minimal error screen.
    Difference
    27%
    Check dated 2026-09-23T01:23:55.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The page shows a revision bump from v3.6.6 to v3.7.0, representing a software version upgrade rather than changes to the study text or structure.
    Difference
    0.0%
    Check dated 2026-09-16T00:29:11.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The revision tag changes from v3.6.5 to v3.6.6. This indicates an incremental backend or documentation update without altering user-facing content.
    Difference
    0.0%
    Check dated 2026-09-01T20:38:54.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.4 to v3.6.5, indicating a minor internal update to the page's content/metadata.
    Difference
    0.0%
    Check dated 2026-08-11T15:56:45.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.3 to v3.6.4, signaling a minor update to the page's metadata.
    Difference
    0.0%
    Check dated 2026-07-28T05:53:36.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    A bibliographic note citing Sindher et al. on the management of gastrointestinal symptoms during oral immunotherapy was added, including PubMed attribution. The revision history was updated from v3.6.2 to v3.6.3.
    Difference
    0.1%
    Check dated 2026-07-06T16:41:43.000Z thumbnail image

Stay in the know with updates to Omalizumab in Multi-Allergen OIT Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Omalizumab in Multi-Allergen OIT Clinical Trial page.